Clinical Trial Update: A Study of MK-8527 in Participants With Moderate and Severe Renal Impairment (MK-8527-008) [Phase 1]

View source ↗

Summary

Phase 1 trial MK-8527-008 in participants with moderate to severe renal impairment has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• MK-8527

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Renal Impairment | Phase 1 | Status: COMPLETED | Results posted: 2026-02-17